Natixis’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-165,763
| Closed | -$4.89M | – | 1255 |
|
|
2025
Q4 | $4.89M | Buy |
+165,763
| New | +$4.5M | 0.02% | 465 |
|
|
2025
Q3 | – | Sell |
-99,111
| Closed | -$2.76M | – | 1172 |
|
|
2025
Q2 | $2.73M | Buy |
+99,111
| New | +$2.61M | 0.01% | 437 |
|
|
2025
Q1 | – | Sell |
-113,966
| Closed | -$4.74M | – | 1126 |
|
|
2024
Q4 | $4.74M | Buy |
113,966
+49,953
| +78% | +$2.39M | 0.03% | 346 |
|
|
2024
Q3 | $4.28M | Sell |
64,013
-182,793
| -74% | -$16.8M | 0.03% | 332 |
|
|
2024
Q2 | $29.3M | Buy |
+246,806
| New | +$31.2M | 0.18% | 103 |
|
|
2024
Q1 | – | Sell |
-49,769
| Closed | -$4.95M | – | 1149 |
|
|
2023
Q4 | $4.95M | Buy |
49,769
+46,649
| +1,495% | +$3.92M | 0.04% | 297 |
|
|
2023
Q3 | $322K | Sell |
3,120
-7,444
| -70% | -$830K | ﹤0.01% | 665 |
|
|
2023
Q2 | $1.28M | Buy |
10,564
+7,344
| +228% | +$980K | 0.01% | 497 |
|
|
2023
Q1 | $495K | Buy |
+3,220
| New | +$531K | ﹤0.01% | 621 |
|
|
2022
Q4 | – | Sell |
-154,124
| Closed | -$18.7M | – | 1264 |
|
|
2022
Q3 | $18.7M | Sell |
154,124
-78,280
| -34% | -$11.9M | 0.09% | 175 |
|
|
2022
Q2 | $33.2M | Buy |
232,404
+176,223
| +314% | +$25.2M | 0.12% | 110 |
|
|
2022
Q1 | $9.68M | Sell |
56,181
-114,692
| -67% | -$19.3M | 0.03% | 418 |
|
|
2021
Q4 | $43.4M | Sell |
170,873
-154,813
| -48% | -$45.3M | 0.15% | 129 |
|
|
2021
Q3 | $125M | Buy |
325,686
+71,169
| +28% | +$26.2M | 0.43% | 37 |
|
|
2021
Q2 | $59.8M | Sell |
254,517
-475,857
| -65% | -$85M | 0.26% | 83 |
|
|
2021
Q1 | $95.6M | Buy |
730,374
+340,465
| +87% | +$49.3M | 0.31% | 66 |
|
|
2020
Q4 | $40.7M | Buy |
389,909
+312,416
| +403% | +$31.6M | 0.15% | 144 |
|
|
2020
Q3 | $5.48M | Sell |
77,493
-175,181
| -69% | -$12.2M | 0.04% | 257 |
|
|
2020
Q2 | $16.2M | Buy |
+252,674
| New | +$13.8M | 0.13% | 140 |
|
|
2019
Q4 | – | Sell |
-24,908
| Closed | -$397K | – | 917 |
|
|
2019
Q3 | $397K | Buy |
24,908
+4,263
| +21% | +$63K | ﹤0.01% | 708 |
|
|
2019
Q2 | $302K | Sell |
20,645
-10,976
| -35% | -$236K | ﹤0.01% | 663 |
|
|
2019
Q1 | $622K | Buy |
+31,621
| New | +$587K | ﹤0.01% | 646 |
|
Other funds holding MRNA
VCM
VPM
